Q1 2026 Management View Dr. Jennifer Buell (Co-Founder, President, CEO & Director) framed recent disclosures around clinical and mechanistic readouts across oncology and pulmonary indications, saying, ...

At a monastery in the Himalayan foothills, a teenage Buddhist lama blesses thousands. One by one, he taps bowed heads with a ...

A federal sentencing on Tuesday of a Frederick man to seven years in prison was the first connected to an MS-13 gang killing ...

Operator: Ladies and gentlemen, thank you for joining, and welcome to the Innate Pharma First Quarter 2026 Business Update and Financial Results.

Detailed price information for Ridgeline Minerals Corp (RDG-X) from The Globe and Mail including charting and trades.

Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with ...

Obexelimab marketing applications for the treatment of IgG4-RD on-target for submission to the FDA this quarter and the EMA in H2 2026 based on the Phase 3 INDIGO IgG4-RD tria ...

Oral presentation to feature 99-patient dataset with extended follow-up in newly diagnosed NPM1-m or KMT2A-r AML –– High CRc rates (90–96%) ...

Enrollment completed in the PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to ...

Registry analysis of 36,148 relapsing-onset cases showed lower annual DMT treatment probability in late-onset versus ...

Background The tobacco industry increasingly targets youth through products such as electronic cigarettes and heated tobacco ...

WJZ Investigator Mike Hellgren came to WJZ in the spring of 2004. Solid reporting credentials and a reputation for breaking important news stories have characterized Mike's work. Mike holds a B.S.